Elanco Animal Health Incorporated Common Stock (ELAN) Stock Price
ELANStock
$24.11+30.68%52W
Market Cap$12.04B
P/E38.83x
PEG Ratio4.04
Div yield—
Beta1.72
ELAN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-20.53%
Price vs S&P 500 (4W)-7.80%
PEG Ratio4.04
VGM Score55.52
P/E Ratio (Annual)38.83x
ELAN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.27 | $0.34 | +26.46%(+$0.07) | |
| Q1 2026 | $0.34 | $0.40 | +16.60%(+$0.06) | |
| Q4 2025 | $0.12 | $0.13 | +11.21%(+$0.01) | |
| Q3 2025 | $0.13 | $0.19 | +43.85%(+$0.06) | |
| Q2 2025 | $0.20 | $0.26 | +29.52%(+$0.06) |
ELAN Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.30
4.32
4.32
4.35
Industry Peers — Pharmaceuticals(570)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ELANElanco Animal Health Incorporated Common Stock | C | B | C | $24.11 |
| LLYEli Lilly & Co. | D | B | C | $1174.61 |
| JNJJohnson & Johnson | D | C | B | $268.04 |
| ABBVABBVIE INC. | D | C | B | $255.48 |
| MRKMerck & Co., Inc. | D | C | B | $148.35 |
| NVSNovartis AG | C | C | C | $153.81 |
| AZNAstraZeneca PLC | C | B | C | $162.70 |
| NVONovo-Nordisk A/S | B | C | C | $45.61 |
| ABTAbbott Laboratories | C | C | C | $112.47 |
| PFEPfizer Inc. | C | D | B | $27.96 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $541.69 |
About Elanco Animal Health Incorporated Common Stock
Elanco Animal Health is a global pharmaceutical company serving the companion and food animal markets with products sold in over 90 countries. The company's portfolio spans cattle, sheep, goats, swine, and companion animals, built through a combination of internal development and strategic acquisitions that have strengthened its market position.